Irbesartan (avapro) manufacturing plant cost?

Question

Accepted Answer

Irbesartan (Avapro) – What Drives the Cost of a Manufacturing Plant?

Building a GMP‑compliant facility to produce irbesartan (the active ingredient in Avapro®) is a major capital investment. The cost can vary dramatically depending on a handful of key factors. Below is a high‑level “road‑map” that can help you estimate a ballpark figure and understand what to ask for when you’re in the detailed planning phase.

Factor	Typical Impact on Cost	Why It Matters
Plant Size / Capacity	1 000 kg / yr – $30–$60 M, 5 000 kg / yr – $60–$120 M, 20 000 kg / yr – $120–$250 M+	Larger plants benefit from economies of scale but also need more equipment, space, and utility capacity.
Geographic Location	U.S./EU: $1 k–$3 k / sq ft; India/China: $400–$800 / sq ft	Land cost, construction labor, local regulatory fees, and proximity to supply chains all shape the price.
Facility Design	Clean‑room grade (ISO‑5 vs ISO‑8), single‑ vs multi‑process, modular vs conventional	Irbesartan synthesis involves multiple unit operations (e.g., nitration, amidation, chromatography). Clean‑room requirements and segregation of hazardous operations add to cost.
Equipment & Process Technology	Batch vs continuous, use of automated chromatography, scale‑up kits	Continuous manufacturing (still emerging for small‑molecule generics) can lower operating costs but requires upfront investment in specialized reactors and control systems.
Regulatory & Compliance	GMP audit trails, environmental permits, waste‑management systems	Compliance adds to construction (e.g., dedicated wastewater treatment) and ongoing operational costs.
Raw Materials & Supply Chain	Cost of the starting materials (e.g., 1‑(2‑hydroxy‑4‑tert‑butyl‑phenyl)-pyrimidin‑2‑yl)-4‑(4‑phenyl‑2‑piperidinyl)-piperazine), solvent recovery	Bulk procurement and storage requirements can inflate initial capital and impact long‑term profitability.
Utilities & Infrastructure	Water, steam, compressed air, HVAC	Irbesartan production requires precise temperature and humidity control, especially for crystallization steps.

Rough Cost Ranges (2024‑2025 Estimates)

Scale	Approx. Total Capital Cost	Notes
Small‑Scale (≤ 5 000 kg / yr)	$30 M – $70 M	Includes core synthesis, chromatography, crystallization, and minimal quality‑control labs.
Mid‑Scale (≈ 10 000 kg / yr)	$70 M – $140 M	Adds more robust analytical labs, larger chromatography trains, and expanded storage.
Large‑Scale (≥ 20 000 kg / yr)	$140 M – $260 M+	Requires multi‑unit, automated processes; often includes dedicated GMP quality‑control building and large solvent‑recovery system.

Tip: These figures are ballpark estimates based on publicly available industrial pharmaceutical plant data (e.g., FDA guidance, GMP manufacturing case studies). Actual costs can differ by ± 20–40 % depending on local conditions, negotiated vendor pricing, and whether you choose to retrofit an existing facility vs. build new.

Where to Get a Precise Estimate

Engineering & Construction Firms – Firms that specialize in pharma GMP facilities (e.g., Kuehne + Nagel Pharma, Gulfstream Group, Gulfstream Group). Request a “pre‑design” or “conceptual design” cost estimate.
Process Development Consultants – They can model your specific synthesis route and help you choose batch vs. continuous operations, which can change the cost dramatically.
Industry Benchmark Studies – Organizations like the Pharmaceutical Industry Association (PIA) publish periodic reports on construction costs.
Regulatory Consultants – They can provide a compliance cost breakdown that is often overlooked (e.g., environmental permits, GMP audits).

A Quick “What‑If” Scenario

Scenario	Plant Size	Rough Cost	Notes
Start‑Up, U.S. (California)	5 000 kg / yr	$60 M	Land is expensive, but state incentives (tax credits, research grants) can reduce net cost.
Scale‑Up, India (Hyderabad)	10 000 kg / yr	$90 M	Lower labor and construction costs, but must account for import duty on specialized equipment.
High‑Throughput, EU (Germany)	20 000 kg / yr	$220 M	Highest regulatory burden and construction costs; but proximity to raw material suppliers can offset some expenses.

Bottom Line

Capital costs for a GMP plant to manufacture irbesartan are typically in the $30–$260 M range depending on scale, location, and technology choices.
Key levers: plant size, batch vs. continuous processes, clean‑room grade, and the choice between building new vs. retrofitting.
Next Steps: Engage a pharma‑focused engineering firm for a concept‑design cost estimate, and parallelly consult a process development specialist to optimize the synthesis route for cost and scalability.

If you have specific parameters (e.g., desired annual throughput, country of operation, preferred process technology), I can help narrow down a more tailored cost estimate. Just let me know!

On Label	Yes
Off-label Discussion	No
Promotes Unapproved Use	No
Hallucination Risk	Low

Ask Questions, Get Industry Insights … Instantly

Recent Questions

Irbesartan (avapro) manufacturing plant cost?

Rough Cost Ranges (2024‑2025 Estimates)

Where to Get a Precise Estimate

A Quick “What‑If” Scenario

Bottom Line

AI-Drug Label Prescribing Information Alignment Report

Grade A

Excellent

Mostly Aligned

Summary

Category Scores

Accurate Statements

Unsupported Statements

Contradictions

Important Omissions

Safety Assessment

Regulatory Assessment

Recommendation

Mostly Aligned

Drug Brand Mention Assessment

Best Known For

Core Claims

Differentiators